Optimizing Anti-VEGF Treatment Outcomes in Neovascular AMD and DME

home / peer-exchange / optimizing-anti-vegf-treatment-outcomes-in-neovascular-amd-and-dme

Expert retina specialists discuss long-term experience with anti-VEGF therapies for age-related macular degeneration and diabetic macular edema, and share evidence-based strategies to improve treatment outcomes.

© 2023 MJH Life Sciences

All rights reserved.